What is the evidence of EPA-based therapy for CV prevention?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglyceridesIntegrating EPA-based therapy in the management of residual CV risk
Prof. Ph. Gabriel Steg, MD
- Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglyceridesUnravelling the triglyceride story
prof. Paul Ridker, MD
